.png){kind=logo}
Chapter 18. Drugs Affecting the Hematopoietic System
Â
Â
____     1.        The
routine monitoring recommended for low molecular weight heparin is:
|
1. |
INR
every 2 days until stable, then weekly |
|
2. |
aPTT
every week while on therapy |
|
3. |
Factor Xa levels if the patient is
pregnant |
|
4. |
White
blood cell count every 2 weeks |
Â
Â
____     2.        When
writing a prescription for warfarin it is common to write _________ on the
prescription.
|
1. |
OK to
substitute for generic |
|
2. |
The brand name of warfarin and Do Not
Substitute |
|
3. |
PRN
refills |
|
4. |
Refills
for 1 year |
Â
Â
____     3.        Education
of patients who are taking warfarin includes discussing their diet.
Instructions include:
|
1. |
Avoiding
all vitamin K-containing foods |
|
2. |
Avoiding high-vitamin K-containing foods |
|
3. |
Increasing
intake of iron-containing foods |
|
4. |
Making
sure they eat 35 grams of fiber daily |
Â
Â
____     4.        Patients
who are being treated with epoetin alfa need to be monitored for the
development of:
|
1. |
Thrombocytopenia |
|
2. |
Neutropenia |
|
3. |
Hypertension |
|
4. |
Gout |
Â
Â
____     5.        The
FDA issued a safety announcement regarding the use of erythropoiesis-stimulating
agents (ESAs) in 2010 with the recommendation that:
|
1. |
ESAs no
longer be prescribed to patients with chronic renal failure |
|
2. |
The risk of tumor development be
explained to cancer patients on ESA therapy |
|
3. |
Patients
should no longer receive ESA therapy to prepare for allogenic transfusions |
|
4. |
ESAs be
prescribed only to patients younger than age 60 years |
Â
Â
____     6.        When
patients are started on darbepoetin alfa (Aranesp) they need monitoring of
their blood counts to determine a dosage adjustment in:
|
1. |
6 weeks if they are a cancer patient |
|
2. |
1 week
if they have chronic renal failure |
|
3. |
2 weeks
if they are taking it for allogenic transfusion |
|
4. |
Each
week throughout therapy |
Â
Â
____     7.        Jim
is having a hip replacement surgery and would like to self-donate blood for the
surgery. In addition to being prescribed epogen alpha he should also be
prescribed:
|
1. |
Folic
acid to prevent megaloblastic anemia |
|
2. |
Iron, to start when the epogen starts |
|
3. |
An
antihypertensive to counter the adverse effects of epogen |
|
4. |
Vitamin
B12 to prevent pernicious anemia |
Â
Â
____     8.        Monitoring
for a patient being prescribed iron for iron deficiency anemia includes:
|
1. |
Reticulocyte count 1 week after therapy
is started |
|
2. |
Complete
blood count every 2 weeks throughout therapy |
|
3. |
Hemoglobin
level at 1 week of therapy |
|
4. |
INR
weekly throughout therapy |
Â
.png)